Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Prediction of Risk for Myeloid Malignancy in Clonal Hematopoiesis
Lachelle D. Weeks, Abhishek Niroula, Donna Neuberg, et al.
NEJM Evidence (2023) Vol. 2, Iss. 5
Open Access | Times Cited: 155

Showing 26-50 of 155 citing articles:

Fifth Edition of the World Health Classification of Tumors of the Hematopoietic and Lymphoid Tissue: Myeloid Neoplasms
Sanam Loghavi, Rashmi Kanagal‐Shamanna, Joseph D. Khoury, et al.
Modern Pathology (2023) Vol. 37, Iss. 2, pp. 100397-100397
Closed Access | Times Cited: 14
Clonal haematopoiesis, ageing and kidney disease
Caitlyn Vlasschaert, Matthew B. Lanktree, Michael J. Rauh, et al.
Nature Reviews Nephrology (2023) Vol. 20, Iss. 3, pp. 161-174
Open Access | Times Cited: 13
Tissue mosaicism following stem cell aging: blood as an exemplar
Chiraag Kapadia, Margaret A. Goodell
Nature Aging (2024) Vol. 4, Iss. 3, pp. 295-308
Closed Access | Times Cited: 5
Five-year follow-up of a phase 2 study of ibrutinib plus fludarabine, cyclophosphamide, and rituximab as initial therapy in CLL
Inhye E. Ahn, Danielle M. Brander, Yue Ren, et al.
Blood Advances (2024) Vol. 8, Iss. 4, pp. 832-841
Open Access | Times Cited: 4
JAK2-mutant Clonal Hematopoiesis is Associated with Venous Thromboembolism
Rebecca L. Zon, Aswin Sekar, Katharine Clapham, et al.
Blood (2024) Vol. 144, Iss. 20, pp. 2149-2154
Closed Access | Times Cited: 4
Clonal hematopoiesis and hematological malignancy
William G. Dunn, Matthew McLoughlin, George S. Vassiliou
Journal of Clinical Investigation (2024) Vol. 134, Iss. 19
Open Access | Times Cited: 4
Challenges in Consensus Regarding the Treatment of Myeloid Malignancies
Hetty E. Carraway
(2025)
Closed Access
Correlates and Consequences of Clonal Hematopoiesis Expansion Rate: A 15-Year Longitudinal Study of 6,986 Women
Yash Pershad, Md Mesbah Uddin, Liying Xue, et al.
medRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Clonal Hematopoiesis in Women With Breast Cancer
Christina Mayerhofer, Rachel A. Freedman, Heather A. Parsons, et al.
Journal of Clinical Oncology (2025)
Closed Access
The Role of Somatic Mutations in Ischemic Stroke: CHIP’s Impact on Vascular Health
Aiman Kinzhebay, Amankeldi A. Salybekov
Neurology International (2025) Vol. 17, Iss. 2, pp. 19-19
Open Access
Fifth edition WHO classification: myeloid neoplasms
Xueyan Chen, Nikhil Patkar, Prashant Tembhare, et al.
Journal of Clinical Pathology (2025), pp. jcp-210022
Closed Access
Biomarkers in clonal haematopoiesis of indeterminate potential (CHIP) linking cardiovascular diseases, myeloid neoplasms and inflammation
Hongtao Tan, Haowen Jiang, Samuel Sherng Young Wang
Annals of Hematology (2025)
Open Access
Clonal hematopoiesis, cardiovascular disease and cancer treatment-induced cardiotoxicity
Nan Zhang, Xu Tian, Dong-Kun Sun, et al.
Seminars in Cancer Biology (2025)
Closed Access
Monitoring CH: time to move beyond VAF?
Lachelle D. Weeks
Blood (2025) Vol. 145, Iss. 9, pp. 907-908
Closed Access
Genetic drivers and clinical consequences of mosaic chromosomal alterations in 1 million individuals
Kun Zhao, Yash Pershad, Hannah Poisner, et al.
medRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Clonal hematopoiesis of indeterminate potential and the risk of autoimmune diseases
Hanzhang Wu, Jiahe Wei, Yuefeng Yu, et al.
Journal of Internal Medicine (2025)
Open Access
TP53‐Mutated Myeloid Neoplasms: 2024 Update on Diagnosis, Risk‐Stratification, and Management
Mithun Vinod Shah, Daniel A. Arber, Devendra Hiwase
American Journal of Hematology (2025)
Open Access
Comparison of treatment-related and de novo CCUS: a retrospective analysis from two centers
Jennifer Santos, Diana Abbott, Grace Bosma, et al.
Leukemia & lymphoma/Leukemia and lymphoma (2025), pp. 1-3
Closed Access
Perspectives on Current Challenges and Emerging Approaches for the Management of CH, MDS, and AML From the 1st Bridging the Gaps in Leukemia, Lymphoma, and Multiple Myeloma Conference
Hetty E. Carraway, Andrew M. Brunner, Catherine Lai, et al.
Clinical Lymphoma Myeloma & Leukemia (2025)
Closed Access
Predicting cytopenias, progression, and survival in patients with clonal cytopenia of undetermined significance: a prospective cohort study
Catherine Cargo, Elsa Bernard, Tumas Beinortas, et al.
The Lancet Haematology (2023) Vol. 11, Iss. 1, pp. e51-e61
Closed Access | Times Cited: 12
Association of Somatic TET2 Mutations With Giant Cell Arteritis
Michelle L. Robinette, Lachelle D. Weeks, Ryan J. Kramer, et al.
Arthritis & Rheumatology (2023) Vol. 76, Iss. 3, pp. 438-443
Open Access | Times Cited: 10
The lifelong natural history of clonal hematopoiesis and its links to myeloid neoplasia
Margarete A. Fabre, George S. Vassiliou
Blood (2023) Vol. 143, Iss. 7, pp. 573-581
Closed Access | Times Cited: 10
Trends in risk for therapy-related myelodysplastic syndrome/acute myeloid leukemia after initial chemo/immunotherapy for common and rare lymphoid neoplasms, 2000–2018
Lindsay M. Morton, Rochelle E. Curtis, Martha S. Linet, et al.
EClinicalMedicine (2023) Vol. 61, pp. 102060-102060
Open Access | Times Cited: 9
Putting comprehensive genomic profiling of ctDNA to work: 10 proposed use cases
Aakash Desai, Lincoln W. Pasquina, Candice Nulsen, et al.
The Journal of Liquid Biopsy (2024) Vol. 4, pp. 100140-100140
Open Access | Times Cited: 3
Germline predisposition for clonal hematopoiesis
Yasuo Kubota, Aaron D. Viny
Seminars in Hematology (2024) Vol. 61, Iss. 1, pp. 61-67
Closed Access | Times Cited: 3

Scroll to top